CRT( Chemo-Radiation Therapy) patterns and short-term outcomes on unresectable NSCLC and SCLC in routine practices in Russia

Trial Identifier: D133HR00026
Sponsor: AstraZeneca
Start Date: March 2023
Primary Completion Date: June 2026
Study Completion Date: June 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Russia Arkhangelsk, Russia
Russia Balashikha, Russia
Russia Barnaul, Russia
Russia Ekaterinburg, Russia
Russia Grozniy, Russia
Russia Irkutsk, Russia
Russia Ivanovo, Russia
Russia Kaluga, Russia
Russia Kazan, Russia
Russia Kemerovo, Russia
Russia Khabarovsk, Russia
Russia Khanty-Mansiysk, Russia
Russia Kirov, Russia
Russia Kostroma, Russia
Russia Krasnodar, Russia
Russia Krasnoyarsk, Russia
Russia Nizhniy Novgorod, Russia
Russia Novokuznetsk, Russia
Russia Novosibirsk, Russia
Russia Obninsk, Russia
Russia Perm, Russia
Russia Podolsk, Russia
Russia Rostov-Na-Donu, Russia
Russia Ryazan, Russia
Russia Saint Petersburg, Russia
Russia Saransk, Russia
Russia Saratov, Russia
Russia Sochi, Russia
Russia Tula, Russia
Russia Tver, Russia
Russia Ulianovsk, Russia
Russia Vladivostok, Russia
Russia Vologda, Russia
Russia Yakutia, Russia
Russia Yaroslavl, Russia
Russia Yuzhno-Sakhalinsk, Russia